Abstract
Background and purpose
Regional nodal irradiation (RNI) is commonly administered in patients with breast cancer with node-positive disease to prevent cancer recurrence. The purpose of this study is to identify whether RNI is associated with greater acute symptom burden from baseline to 1 to 3 months post completion of radiotherapy (RT) when compared to localized RT.
Materials and methods
Patient and treatment characteristics were collected prospectively for breast cancer patients with and without RNI from February 2018 to September 2020. The Edmonton Symptom Assessment System (ESAS) and Patient-Reported Functional Status (PRFS) tool were completed by patients at baseline, weekly during RT, and at a 1- to 3-month follow-up visit. The Wilcoxon rank-sum or Fisher exact tests were used to compare variables between patients with or without RNI.
Results
A total of 781 patients were included in the analysis. Baseline symptom reporting was similar between cohorts, with the exception of PRFS scores (p = 0.0023), which were worse in patients receiving RNI. Across all time points, differences in outcomes between cohorts were minimal, except for lack of appetite (p = 0.03) and PRFS scores (p = 0.049), which were significantly aggravated in patients treated with RNI.
Conclusion
There is insufficient evidence to suggest that RNI is associated with greater symptom burden as assessed with the ESAS. Further research should be conducted over a longer time period to determine the impact of late effects of RNI on patient-reported symptoms.
Similar content being viewed by others
Data availability
The datasets will become available upon request.
References
Rojas K, Stuckey A (2016) Breast cancer epidemiology and risk factors. Clin Obstet Gynecol 59(4):651–672
McQuestion M (2011) Evidence-based skin care management in radiation therapy: clinical update. Semin Oncol Nurs 27(2):e1-17
Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A et al (2015) Regional nodal irradiation in early-stage breast cancer. N Engl J Med 373(4):307–316
Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H et al (2015) Internal Mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 373(4):317–327
Dodwell D, Taylor C, McGale P, Coles C, Duane F, Gray R et al (2019) Abstract GS4–02: Regional lymph node irradiation in early stage breast cancer: an EBCTCG meta-analysis of 13,000 women in 14 trials. Cancer Res. 79(4_Supplement):GS4-02
Rudra S, Roy A, Brenneman R, Gabani P, Roach MC, Ochoa L et al (2021) Radiation-induced brachial plexopathy in patients with breast cancer treated with comprehensive adjuvant radiation therapy. Adv Radiat Oncol 6(1):100602
Moreno AC, Shaitelman SF, Buchholz TA (2017) A clinical perspective on regional nodal irradiation for breast cancer. The Breast 34:S85-90
Schaue D, Kachikwu EL, McBride WH (2012) Cytokines in radiobiological responses: a review. Radiat Res 178(6):505–523
Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW (2011) Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol 29(26):3517–3522
Canadian Cancer Society. Side effects of radiation therapy [Internet]. Side effects of radiation therapy. Available from: https://cancer.ca/en/treatments/treatment-types/radiation-therapy/side-effects-of-radiation-therapy#:~:text=Most%20side%20effects%20generally%20go,months%20or%20years%20after%20treatment.
Canadian Cancer Society. Radiation therapy for breast cancer [Internet]. Radiation therapy for breast cancer. Available from: https://cancer.ca/en/cancer-information/cancer-types/breast/treatment/radiation-therapy
Wang K, Tepper JE (2021) Radiation therapy-associated toxicity: etiology, management, and prevention. CA Cancer J Clin 71(5):437–454
Hsiao CP, Daly B, Saligan LN (2016) The etiology and management of radiotherapy-induced fatigue. Expert Rev Qual Life Cancer Care 1(4):323–328
Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol Off J Am Soc Clin Oncol 18(4):743–753
Yennurajalingam S, Barla SR, Arthur J, Chisholm GB, Bruera E (2019) Frequency and characteristics of drowsiness, somnolence, or daytime sleepiness in patients with advanced cancer. Palliat Support Care 17(4):459–463
Tevis SE, James TA, Kuerer HM, Pusic AL, Yao KA, Merlino J et al (2018) Patient-reported outcomes for breast cancer. Ann Surg Oncol 25(10):2839–2845
Lam E, Wong G, Karam I, Zhang L, Lou J, McCurdy-Franks E et al (2022) Impact of adjuvant breast radiotherapy on patient-reported fatigue. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 30(2):1283–1291
Lam E, Wong G, Zhang L, Drost L, Karam I, Yee C et al (2021) Self-reported pain in breast cancer patients receiving adjuvant radiotherapy. Support Care Cancer 29(1):155–167
Wan BA, Pidduck W, Zhang L, Nolen A, Drost L, Yee C et al (2019) Patient-reported fatigue in breast cancer patients receiving radiation therapy. Breast Edinb Scotl 47:10–15
Misra S, Lee G, Swain M, Korzets Y, Le L, Lau A et al (2018) Patient-reported acute fatigue in elderly breast cancer patients treated with and without Regional Nodal Radiation. Int J Radiat Oncol Biol Phys 102(3):e748–e749
Taunk NK, Haffty BG, Chen S, Khan AJ, Nelson C, Pierce D et al (2011) Comparison of radiation-induced fatigue across 3 different radiotherapeutic methods for early stage breast cancer. Cancer 117(18):4116–4124
Reidunsdatter RJ, Rannestad T, Frengen J, Frykholm G, Lundgren S (2011) Early effects of contemporary breast radiation on health-related quality of life - predictors of radiotherapy-related fatigue. Acta Oncol Stockh Swed 50(8):1175–1182
Schnur JB, Ouellette SC, DiLorenzo TA, Green S, Montgomery GH (2011) A qualitative analysis of acute skin toxicity among breast cancer radiotherapy patients. Psychooncology 20(3):260–268
Parekh A, Dholakia AD, Zabranksy DJ, Asrari F, Camp M, Habibi M et al (2018) Predictors of radiation-induced acute skin toxicity in breast cancer at a single institution: role of fractionation and treatment volume. Adv Radiat Oncol 3(1):8–15
Chow S, Wan BA, Pidduck W, Zhang L, DeAngelis C, Chan S et al (2019) Symptom clusters in patients with breast cancer receiving radiation therapy. Eur J Oncol Nurs 42:14–20
Gross JP, Sachdev S, Helenowski IB, Lipps D, Hayes JP, Donnelly ED et al (2018) Radiation therapy field design and lymphedema risk after regional nodal irradiation for breast cancer. Int J Radiat Oncol Biol Phys 102(1):71–78
Kalemikerakis I, Evaggelakou A, Kavga A, Vastardi M, Konstantinidis T, Govina O (2021) Diagnosis, treatment and quality of life in patients with cancer-related lymphedema. J BUON Off J Balk Union Oncol 26(5):1735–1741
Warade AC, Jha AK, Pattankar S, Desai K (2019) Radiation-induced brachial plexus neuropathy: a review. Neurol India 67(Supplement):S47-52
Acknowledgements
We thank the support of the breast radiation oncologists and radiation review nurses.
Funding
Generous support provided by Bratty Family Fund, Michael and Karyn Goldstein Cancer Research Fund, Joey and Mary Furfari Cancer Research Fund, Pulenzas Cancer Research Fund, Joseph and Silvana Melara Cancer Research Fund, and Ofelia Cancer Research Fund.
Author information
Authors and Affiliations
Contributions
Irene Karam and Edward Chow contributed to the design of the study. Tara Behroozian and Lauren Milton assisted in data collection. Liying Zhang and Julia Lou contributed to the data analysis and prepared the tables and figures. Tara Behroozian, Lauren Milton, Saba Shariati, and Edward Chow contributed to the drafting of the manuscript. All the authors contributed to the review and editing of the manuscript.
Corresponding author
Ethics declarations
Ethics approval
This study was approved by the Sunnybrook Health Sciences Centre Research Ethics Board.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendices
Appendix 1 Outcome assessment tools
A1. Edmonton Symptom Assessment System (ESAS)
A2. Patient-Reported Functional Status (PRFS) Tool
Over the past month, I would generally rate my activity as:
х Normal with no limitations (0)
х Not my normal self, but able to be up and about with fairly normal activities (1)
х Not feeling up to most things, but in bed or chair less than half the day (2)
х Able to do little activity & spend most of the day in bed or chair (3)
х Pretty much bedridden, rarely out of bed (4)
Appendix 2
Appendix 3
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Behroozian, T., Milton, L., Zhang, L. et al. A comparison of acute patient-reported outcomes in breast cancer patients with and without regional nodal irradiation using the ESAS and PRFS tool. Support Care Cancer 31, 279 (2023). https://doi.org/10.1007/s00520-023-07728-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00520-023-07728-0